ziprasidone has been researched along with Depression, Endogenous in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Duggal, HS; Singh, I | 1 |
| Altun, NS; Budak, F; Dündar, S; Kutlu, A | 1 |
| Ash, P; Craighead, WE; Jacob, MK | 1 |
| Ghaemi, SN; Gilmer, W; Holtzman, N; Pae, CU; Patkar, AA; Thommi, SB | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; ValentÃ, M; Vieta, E | 1 |
| Maharaj, K; Privitera, MR | 1 |
| Barbee, JG; Conrad, EJ; Jamhour, NJ | 1 |
| Baldessarini, RJ; Berry, JM; Centorrino, F; Fogarty, KV; Kidwell, JE; MacLean, E; Salvatore, P | 1 |
| Anders, JL | 1 |
| Mech, AW | 1 |
| Keck, PE; McElroy, SL; Strakowski, SM | 1 |
2 review(s) available for ziprasidone and Depression, Endogenous
| Article | Year |
|---|---|
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Depression; Depressive Disorder; Dibenzothiazepines; Hostility; Humans; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Thiazoles; Treatment Outcome | 2000 |
1 trial(s) available for ziprasidone and Depression, Endogenous
| Article | Year |
|---|---|
Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Young Adult | 2012 |
9 other study(ies) available for ziprasidone and Depression, Endogenous
| Article | Year |
|---|---|
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
New-onset vascular mania in a patient with chronic depression.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dementia, Vascular; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone induced tardive cervical dystonia.
Topics: Antipsychotic Agents; Botulinum Toxins, Type A; Clonazepam; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neuromuscular Agents; Piperazines; Thiazoles | 2009 |
Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.
Topics: Depressive Disorder; Female; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Thiazoles | 2012 |
Mania from dose-related ziprasidone augmentation of an SSRI.
Topics: Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2003 |
The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone: first year experience in a hospital setting.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Female; Hospitalization; Humans; Inpatients; Length of Stay; Long QT Syndrome; Male; Middle Aged; Mood Disorders; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Applying parsimony to "An African patient with ziprasidone intolerance".
Topics: Antipsychotic Agents; Anxiety Disorders; Black or African American; Culture; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Pharmacogenetics; Piperazines; Polymorphism, Genetic; Thiazoles | 2005 |
High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Treatment Outcome | 2008 |